MedTrace Logo

Analgesia in Laparoscopic Cholecystectomy

NCT01388946 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2016-07-06

Study results available
· View outcomes & findings →

Summary

The investigators hypothesis is that perioperative infusion of 0.75 ropivacaine in patients undergoing laparoscopic cholecystectomy may modify the intensity of postoperative pain or the analgesic consumption during the first 24 hours.

Conditions

  • Pain, Postoperative
  • Chronic Postoperative Pain

Interventions

DRUG

Ropivacaine 0.75

DRUG

Normal saline

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Emilia Vassi · St Savvas Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01388946 on ClinicalTrials.gov